Showing results (1-10 of 222) with videos related to
Sort By:
Pageof 23
Handbook of Clinical Neurology|September 28, 2024
Viral and nonviral approachesMikko Airavaara, Mart SaarmaPharmacology & Therapeutics|January 30, 2024
CDNF and ER stress: Pharmacology and therapeutic possibilitiesHelike Lõhelaid, Mart Saarma, Mikko AiravaaraHuman Gene Therapy|July 16, 2015
Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene TherapyAndrii Domanskyi, Mart Saarma, Mikko AiravaaraFEBS Letters|October 10, 2015
Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's diseaseMerja H Voutilainen, Urmas Arumäe, Mikko Airavaara, et al.Synapse (New York, N.Y.)|January 27, 2006
In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is alteredMikko Airavaara, Jelena Mijatovic, Tanja Vihavainen, et al.The European Journal of Neuroscience|November 5, 2004
Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout miceMikko Airavaara, Anu Planken, Helena Gäddnäs, et al.Eneuro|October 31, 2017
MANF Is Essential for Neurite Extension and Neuronal Migration in the Developing CortexKuan-Yin Tseng, Tatiana Danilova, Andrii Domanskyi, et al.The Journal of Comparative Neurology|April 29, 2009
Mesencephalic astrocyte-derived neurotrophic factor reduces ischemic brain injury and promotes behavioral recovery in ratsMikko Airavaara, Hui Shen, Chi-Chung Kuo, et al.Journal of Neurochemistry|February 6, 2008
Characterization of the striatal dopaminergic neurotransmission in MEN2B mice with elevated cerebral tissue dopamineJelena Mijatovic, Outi Patrikainen, Leonid Yavich, et al.Eneuro|February 2, 2020
MANF Ablation Causes Prolonged Activation of the UPR without Neurodegeneration in the Mouse Midbrain Dopamine SystemEmmi Pakarinen, Tatiana Danilova, Vootele Võikar, et al.Pageof 23